journal article·2022-01-26

Multivalent Supramolecular Assembly Based on a Triphenylamine Derivative for Near-Infrared Lysosome Targeted Imaging

Jie Yu, Hui Wang, Xianyin Dai, Yong Chen, Yu Liu

Publisher page

Abstract

Near-infrared (NIR) targeted cell imaging has become a research hotspot due to the advantages of deeper tissue penetration, minimal interference from the background signals, and lower light damage. Herein, we report a multivalent supramolecular aggregate with NIR fluorescence emission, which was fabricated from triphenylamine derivatives (TPAs), cucurbit[8]uril (CB[8]), Si-rhodamine (SiR), and hyaluronic acid (HA). Interestingly, possessing a rigid luminescent core and cationic phenylpyridinium units linked by flexible alkyl chains, the tripaddle hexacationic TPA could bind with CB[8] at a 2:3 stoichiometric ratio to form a network-like multivalent assembly with enhanced red luminescence. Such organic two-dimensional network-like aggregate further co-assembled with the energy acceptor SiR and cancer cell targeting agent HA, leading to nanoparticles with NIR emission at 675 nm via an intermolecular energy transfer pathway. Furthermore, the obtained multivalent supramolecular aggregate was successfully applied in lysosome targeted imaging toward A549 cancer cells, which provides a convenient strategy for NIR targeted cell imaging.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Luminescence and Fluorescent Materials · Supramolecular Chemistry and Complexes · Molecular Sensors and Ion Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, P.R. China

Funding

Natural Science Foundation of?Hunan Province · National Natural Science Foundation of China

References (28)

Show source-provided references
1. 10.1039/C6SC00970K10.1039/C6SC00970K ↗
2. 10.1002/adma.20200468510.1002/adma.202004685 ↗
3. 10.1021/jacs.9b0716210.1021/jacs.9b07162 ↗
4. 10.1021/acsami.6b0427610.1021/acsami.6b04276 ↗
5. 10.1021/acsami.0c0176210.1021/acsami.0c01762 ↗
6. 10.1021/ar500109h10.1021/ar500109h ↗
7. 10.1039/B603082N10.1039/B603082N ↗
8. 10.1021/ja106362w10.1021/ja106362w ↗
9. 10.1021/jacs.0c0765110.1021/jacs.0c07651 ↗
10. 10.1038/s41557-018-0164-y10.1038/s41557-018-0164-y ↗
11. 10.1002/adom.20200170210.1002/adom.202001702 ↗
12. 10.1039/D0SC05343K10.1039/D0SC05343K ↗
13. 10.1002/anie.20200462210.1002/anie.202004622 ↗
14. 10.1002/asia.20210059410.1002/asia.202100594 ↗
15. 10.1016/j.cclet.2021.08.00110.1016/j.cclet.2021.08.001 ↗
16. 10.1021/acs.accounts.1c0033610.1021/acs.accounts.1c00336 ↗
17. 10.1002/anie.20191451310.1002/anie.201914513 ↗
18. 10.1021/jacs.1c0674110.1021/jacs.1c06741 ↗
19. 10.1021/jacs.6b0122310.1021/jacs.6b01223 ↗
20. 10.1039/C9CC07144J10.1039/C9CC07144J ↗
21. 10.1002/adfm.20170514110.1002/adfm.201705141 ↗
22. 10.1039/D0SC00473A10.1039/D0SC00473A ↗
23. 10.1002/anie.20180737310.1002/anie.201807373 ↗
24. 10.1002/smll.20210118510.1002/smll.202101185 ↗
25. 10.1021/jacs.0c0678310.1021/jacs.0c06783 ↗
26. 10.1016/j.dyepig.2020.10874810.1016/j.dyepig.2020.108748 ↗
27. 10.1021/acs.biomac.9b0056410.1021/acs.biomac.9b00564 ↗
28. 10.1021/nn204123p10.1021/nn204123p ↗